MENU
Showcases Stock ranks Forex

Axonics Inc (AXNX)
67.6  -0.12 (-0.18%) 04-12 16:00
Open: 67.75 Pre. Close: 67.72
High: 67.775 Low: 67.52
Volume: 904,033 Market Cap: 3,448(M)
Stock Technical Analysis
Overall:     
Target: Six months: 80.36
One year: 81.37
Support: Support1: 67.40
Support2: 56.08
Resistance: Resistance1: 68.80
Resistance2: 69.67
Pivot: 68.38
Moving Averages: MA(5): 67.70
MA(20): 68.37
MA(100): 64.95
MA(250): 58.64
MACD: MACD(12,26): -0.05
Signal(12,26,9): 0.12
%K %D: %K(14,3): 5.39
%D(3): 6.37
RSI: RSI(14): 43.02
52-Week: High: 69.68
Low: 47.59
Change(%): 17.9
Average Vol(K): 3-Month: 980
10-Days: 1136
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 67.938 - 68.273 68.273 - 68.544
Low: 66.575 - 67.04 67.04 - 67.417
Close: 66.956 - 67.652 67.652 - 68.217
Price, MAs and Bollinger Bands
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.

[ AXNX ] has closed above bottom band by 20.9%. Bollinger Bands are 48.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 52 bars. This is a sign that the market may be about to initiate a new trend.
Company profile
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Stock chart
Stock News
Fri, 12 Apr 2024
SG Americas Securities LLC Sells 14470 Shares of Axonics, Inc. (NASDAQ:AXNX) - Defense World

Wed, 10 Apr 2024
Stratos Wealth Partners LTD. Makes New $1.30 Million Investment in Axonics, Inc. (NASDAQ:AXNX) - Defense World

Tue, 09 Apr 2024
Axonics, Inc. (NASDAQ:AXNX) Holdings Trimmed by Peregrine Capital Management LLC - MarketBeat

Sat, 30 Mar 2024
Axonics Modulation Technologies Inc (AXNX) CEO Raymond W Cohen Sold $700,700 of Shares - AOL

Thu, 29 Feb 2024
Axonics Responds to ITC Action by Medtronic - Business Wire

Wed, 28 Feb 2024
Axonics Inc (AXNX) Reports Robust Revenue Growth and Margin Expansion in Q4 and FY 2023 - Yahoo Finance

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Underperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Outperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Global Select
Sector:  Healthcare
Industry:  Medical - Devices
Shares Out. (M) 51.00
Shares Float (M) 50.43
% Held by Insiders 1.07
% Held by Institutions 102.09
Shares Short (K) 2940
Shares Short Prior Month (K) 2650
Stock Financials
EPS -0.120
Book Value (p.s.) 12.560
Profit Margin -1.66
Operating Margin 3.93
Return on Assets (ttm) -0.4
Return on Equity (ttm)
Qtrly Rev. Growth 27.7
Gross Profit (p.s.)
Sales Per Share 7.184
EBITDA (p.s.) 0.153
Qtrly Earnings Growth 844.80
Operating Cash Flow (M) -2.02
Levered Free Cash Flow (M) -6.82
Stock Valuation
PE Ratio -563.33
PEG Ratio 2.77
Price to Book value 5.38
Price to Sales 9.41
Price to Cash Flow -1706.73
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android